Inhibition of FASN (fatty acid synthase) reduces (SFAs) and (MUFAs), regulating the process of including PUFAs into phospholipids (PLs) of mutant KRAS lung cancer cells, and increasing their sensitivity to ferroptosis [89]. This evidence concerns the gene FASN and lung carcinoma.